The investment objective of the Fund is to replicate the performance of the MSCI China Index (the “Index”), while minimising as far as possible the tracking error between the Fund’s performance and that of the Index. The Index is a market-capitalisation weighted index designed to measure the performance of the largest Chinese companies, as listed in Hong Kong. Chinese equity markets are considered to be emerging markets and, accordingly, are subject to specific risk factors. In seeking to achieve its investment objective, the Fund will invest in securities included in the Index using a strategy of Optimised Replication, where the Fund invests in a representative sample of the constituents of the Index.